e-learning
resources
Virtual 2021
05.09.2021
Biomarkers for the management of bronchial obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An innovative high sensitivity tool for active neutrophil elastase quantification
S. Johnston (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), D. McCafferty (Belfast (Belfast), United Kingdom)
Source:
Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Session:
Biomarkers for the management of bronchial obstructive diseases
Session type:
E-poster
Number:
1141
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Johnston (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), D. McCafferty (Belfast (Belfast), United Kingdom). An innovative high sensitivity tool for active neutrophil elastase quantification. 1141
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Investigating optimal sputum processing methods for active neutrophil elastase quantification
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
The development of a novel immunoassay for the quantification of active tryptase
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019
A rapid method to increase the clinical use of sputum inflammatory cells
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
New method for rapid and dynamic quantification of elastase activity on sputum neutrophils from patients with cystic fibrosis using flow cytometry
Source: Eur Respir J, 55 (4) 1902355; 10.1183/13993003.02355-2019
Year: 2020
PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF
Source: ERS Lung Science Conference 2021
Year: 2021
Development of a novel immunoassay for the measurement of active plasmin in patients with IPF
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015
Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination?
Source: Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019
Year: 2019
Treatment step-up strategy based on sputum eosinophil levels does not yield any better results than standard strategy
Source: Eur Respir J 2005; 26: Suppl. 49, 574s
Year: 2005
A phenotypic high-throughput screening assay for the pharmacological inhibition of the pathological deposition of extracellular matrix
Source: ERS Lung Science Conference 2018
Year: 2018
Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept